While recent years has brought the breakthrough medicine Gleevec for CML and this year two new frontline medicines, some patients still need better options. Dr. Jorge Cortes says such options are now showing promise and he explains the latest news.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…